($NOVN (-0,1 %) ) - Novartis clearly exceeds expectations
Things are currently going well for the Basel-based pharmaceutical group.
It has once again raised its forecast for the year. It is now targeting growth in core operating profit in the mid to high teens. Previously, he had assumed an increase in the low double-digit percentage range to the mid-teens. In the second quarter, the SMI Group increased its operating profit by a whopping 43% to $4 billion. The much-noticed core operating profit rose to just under $5 billion and exceeded analysts' expectations. At the bottom line, Novartis earned $3.2 billion. Sales increased by 9% to $12.5 billion. Novartis had already raised its forecast for the year after the first quarter.
Love it.
Happy Investing
GG